Hsp90 Inhibition Accelerates Cell Lysis - Journal of Biological Chemistry
Antibiotics | Free Full-Text | Regulation of Geldanamycin Biosynthesis by Cluster-Situated Transcription Factors and the Master Regulator PhoP | HTML
Hsp90 - Wikipedia
Geldanamycin - an overview | ScienceDirect Topics
Geldanamycin - an overview | ScienceDirect Topics
Scheme 27 Design and chemical synthesis of maytansine-geldanamycin... | Download Scientific Diagram
The chemical structures of 17-allylamino-17demethoxygeldanamycin... | Download Scientific Diagram
Geldanamycin as depletor of Hsp90. Primarily Hsp90 client protein binds... | Download Scientific Diagram
The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors
Geldanamycin – HOPES Huntington's Disease Information
Geldanamycin | Hsp90 Inhibitor | MedChemExpress
Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti‐inflammatory effects and interacts with glucocorticoid receptor in vivo - Bucci - 2000 - British Journal of Pharmacology - Wiley Online Library
Geldanamycin: The Prototype of a Class of Antitumor Drugs Targeting the Heat Shock Protein 90 Family of Molecular Chaperones
Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90 | Nature Chemistry
Structural development of HSP90 inhibitors. Geldanamycin (I) and... | Download Scientific Diagram
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs | Leukemia
Different inhibitors of Hsp90 with their action mechanism. Naturally... | Download Scientific Diagram
Targeting Heat Shock Proteins in Multiple Myeloma | SpringerLink
Geldanamycin - an overview | ScienceDirect Topics
Geldanamycin - an overview | ScienceDirect Topics
Geldanamycin - an overview | ScienceDirect Topics
Inhibitors of the heat shock protein 90: from cancer clinical trials to neurodegenerative diseases
Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent: Cell
HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasia
